Skip to main content
logo
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
6.81
-0.01 (-0.15%)
Mar 24, 2026, 12:01 PM EST

Knight Therapeutics Revenue

In the year 2025, Knight Therapeutics had annual revenue of 450.09M CAD with 21.22% growth. Knight Therapeutics had revenue of 133.11M in the quarter ending December 31, 2025, with 37.42% growth.

Revenue
450.09M
Revenue Growth
+21.22%
P/S Ratio
1.49
Revenue / Employee
604.14K
Employees
745
Market Cap
668.60M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025450.09M78.78M21.22%
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 201947.46M34.96M279.69%
Dec 31, 201812.50M3.87M44.78%
Dec 31, 20178.63M2.69M45.35%
Dec 31, 20165.94M4.90M472.81%
Dec 31, 20151.04M672.00K184.11%
Dec 31, 2014365.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Trulieve Cannabis1.62B
Green Thumb Industries1.61B
Verano Holdings1.13B
Cresco Labs899.24M
Aurora Cannabis373.12M
TerrAscend357.26M
Organigram Global279.99M
Canopy Growth278.39M
Revenue Rankings

Knight Therapeutics News

More News